Ipilimumab vs Irbesartan

## Ipilimumab vs Irbesartan: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Irbesartan**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Irbesartan**: Selective non-competitive angiotensin II type 1 receptor antagonist.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Irbesartan — 11-15 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Irbesartan — C25H28N6O.

**Molecular Weight**: Ipilimumab — N/A; Irbesartan — 428.5320 g/mol.

**Type**: Ipilimumab — Antibody; Irbesartan — Small molecule.